Proton Therapy for Lymph Nodes in Breast Cancer
Completed · Not applicable
Conditions studied: Breast Cancer
In brief
The purpose of this study is to determine if proton radiation therapy will reduce the amount of heart that is exposed to radiation, thereby decreasing the frequency and/or severity of any cardiac side effects.
Key facts
- Study ID
- NCT01365845
- Run by
- University of Florida
- People needed
- 18
- Starts
- 2012-04-01
- Expected to finish
- 2018-05-23
- Last updated by the study team
- 2018-06-29
Who can join
Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Pathologically confirmed invasive adenocarcinoma of the breast stage I-III (TX, T0-4, N0-3) with medially located tumor and/or axillary node invasion.
- Patients must have undergone either mastectomy or breast conservation surgery.
- Patients are required to have axillary staging which can include sentinel node biopsy alone if sentinel node is negative.
- Patient must require peripheral lymph node radiation per physician discretion.
You may not qualify if…
- Evidence of distant metastasis (M1).
- Prior radiotherapy to the area of interest.
- Prior history of cardiovascular disease per physician discretion.
- Prior or concurrent cancer other than non-melanomatous skin cancer unless disease free for at least 5 years.
- Collagen vascular disease, specifically dermatomyositis with a CPK level above normal or with an active skin rash, systemic lupus erythematosis or scleroderma.
Where it is running
- University of Florida Proton Therapy Institute — Jacksonville, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.